Pertussin-Ch - instructions for use, dose, side effects, contraindications

Similar drugsTo uncover

Dosage form: & nbspsyrup

Composition:

Per 100 g:

active substances: thyme extract liquid 12.0 g, potassium bromide 1.0 g;

Excipients: sucrose solution 64% (sugar syrup) 82.0 g, ethanol (ethyl alcohol) 95% 4.06 g, purified water 0.94 g.

Description:A thick liquid of brown color, with a fragrant smell.

Pharmacotherapeutic group:expectorant

ATX: & nbsp

Expectorants

Pharmacodynamics:

Combined drug. The herb extract of thyme exerts an expectorant effect, increases the amount of secretory mucous membranes of the upper respiratory tract, facilitates the dilution of sputum and accelerates its evacuation. Potassium bromide reduces the excitability of the central nervous system.

Pharmacokinetics:No data available.

Indications:

As an expectorant in the complex therapy of acute respiratory diseases; tracheitis, bronchitis, and also in children with whooping cough.

Contraindications:

Hypersensitivity to the components of the drug, liver disease, alcoholism, craniocerebral trauma, brain disease, epilepsy, chronic heart failure (decompensated), sucrose / isomaltose deficiency, fructose intolerance, glucose-galactose malabsorption, pregnancy, breastfeeding period, children's age (up to 3 years).

Carefully:

Diabetes mellitus, children age over 3 years (due to the presence of ethanol in the drug).

Dosing and Administration:

The drug is taken orally, after a meal (due to the possibility of reducing appetite).

Adults 1 tablespoon 3 times a day;

children from 3 to 6 years - 14-1 teaspoonful 3 times a day;

children from 6 to 12 years old - 1-2 teaspoons 3 times a day;

children over 12 years - 1 dessert spoon 3 times a day.

The course of treatment is 10-14 days. An increase in the duration and conduct of repeated courses of treatment is possible on the recommendation of a doctor.

Side effects:

Allergic reactions, heartburn are possible.

Overdose:

In case of an overdose of the drug, nausea is possible.

Treatment: symptomatic.

Interaction:

The drug should not be used simultaneously with antitussive drugs, as this makes it difficult to cough up thinned phlegm.

Special instructions:

The drug contains 8-11% ethanol. The content of absolute alcohol is: in 1 teaspoonful (5 ml) to 0.43 g, in 1 dessert spoon (10 ml) - up to 0.87 g, in 1 tablespoon (15 ml) - up to 1.3 g. the maximum daily dose of the drug for adults - 3 tablespoons (45 ml) - contains up to 3.9 grams of absolute ethyl alcohol.

Indication for patients with diabetes mellitus: the content of sucrose in 1 teaspoonful (5 ml) of the preparation corresponds to about 0.32 XE, in 1 dessert spoon (10 ml) - about 0.64 XE; in 1 tablespoon - about 0,96 XE.

Effect on the ability to drive transp. cf. and fur:

During the treatment period, care must be taken when driving vehicles, working with moving mechanisms, and engaging in other potentially hazardous activities requiring increased attention and speed of psychomotor reactions.

Form release / dosage:Syrup.

Packaging:

For 100, 125 g of the drug in bottles of orange glass, sealed with plastic caps and plastic screw caps made of polymer materials.

To 100.125 g of the drug in bottles of orange glass from glass mass with a screw neck type FVB or FVZ, corked with aluminum caps or aluminum caps with perforations.

Each bottle is placed in a cardboard box, on which the full text of the instruction for medical use is written.

It is allowed to pack vials without a cardboard pack together with a corresponding number of instructions for medical use in a group container.

Storage conditions:

In a dry place at a temperature of 12 to 15 FROM.

Keep out of the reach of children.

Shelf life:4 years.

Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe

Registration number:LP-000247

Date of registration:16.02.2011

The owner of the registration certificate:KIROVSKAYA PHARMACEUTICAL COMPANY, LTD. KIROVSKAYA PHARMACEUTICAL COMPANY, LTD. Russia

Manufacturer: & nbsp

KIROVSKAYA PHARMACEUTICAL FACTORY, OJSC Russia

Representation: & nbspKIROVSKAYA PHARMACEUTICAL FACTORY, OJSCKIROVSKAYA PHARMACEUTICAL FACTORY, OJSC

Information update date: & nbsp18.03.2016

Illustrated instructions

Instructions

Pertussin-Ch (Pertussin-C)